logo

For the Inventor, By the Inventor

Bergen, Norway

Bergenbio Asa

Calculating rank
USPTO Granted Patents = 13

% Expired Patents = 38.5


Trademarks = 5

Forward Citations = 15

Loading Chart...
Loading Chart...

21 inventors (with patents filed for the assignee):

goldMedal David Robert Micklem (8 out of 11 patents)

silverMedal Linn Nilsson (7 out of 8 patents)

bronzeMedal Sergej Kiprijanov (6 out of 14 patents)

4.  Lavina Ahmed (6 out of 7 patents)

5.  James Bradley Lorens (5 out of 14 patents)

6.  Tone Sandal (3 out of 4 patents)

7.  Hallvard Haugen (3 out of 3 patents)

8.  Stuart Thomas Onions (2 out of 67 patents)

9.  John Paul Watts (2 out of 11 patents)

10.  Jason John Shiers (2 out of 6 patents)

11.  Mohammed Abdul Quddus (2 out of 2 patents)

12.  Joseph William Wrigglesworth (2 out of 6 patents)

13.  Colin Peter Sambrook-Smith (2 out of 4 patents)

14.  Alan Naylor (2 out of 65 patents)

15.  Derek John Londesbrough (2 out of 11 patents)


13 patents:

1. 11732048 - Anti-axl antagonistic antibodies (2023-08-22),
2. 11584796 - Anti-Axl antagonistic antibodies (2023-02-21),
3. 11534440 - Combination therapy with Axl inhibitor and immune checkpoint modulator or oncolytic virus (2022-12-27),
4. 11198734 - Anti-Axl antagonistic antibodies (2021-12-14),
5. 11186643 - Anti-Axl antibodies (2021-11-30),
6. 11059893 - Humanized anti-AXL antibodies (2021-07-13),
7. 11035008 - Biomarkers for cancer (2021-06-15),
8. 10766861 - Pharmaceutically active compounds (2020-09-08),
9. 10336702 - Pharmaceutically active compounds (2019-07-02),
10. 10317405 - Methods of detecting Akt3 and administering Ax1 inhibitor (2019-06-11),
11. 9975954 - Anti-Axl antibodies (2018-05-22),
12. 9975953 - Anti-Axl antibodies (2018-05-22),
13. 9783801 - Methods for creating and identifying functional RNA interference elements (2017-10-10),
Company Overview
Bergenbio Asa is a biotechnology company based in Bergen, Norway, specializing in the development of innovative therapies for cancer treatment. The company focuses on advancing its proprietary drug candidates through clinical trials, leveraging its expertise in biopharmaceutical research. Bergenbio is committed to addressing unmet medical needs in oncology by utilizing cutting-edge technology and scientific knowledge to create effective therapeutic solutions. Its research initiatives aim to enhance patient outcomes and contribute to the evolving landscape of cancer care.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 27 2026

13 Patents

#3 in Bergen

#128 in Norway

#45,104 in the World

Bergen, NO
Bergen, Norway

Bergenbio Asa

Forward Citations = 15

21 inventors:

goldMedal David Robert Micklem (8 out of 11 patents)

silverMedal Linn Nilsson (7 out of 8 patents)

bronzeMedal Sergej Kiprijanov (6 out of 14 patents)

4.  Lavina Ahmed (6 out of 7 patents)

5.  James Bradley Lorens (5 out of 14 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bergenbio Asa. Retrieved from https://idiyas.com/company/bergenbio-asa

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…